A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 34,553 shares of MRK stock, worth $3.43 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
34,553
Previous 31,303 10.38%
Holding current value
$3.43 Million
Previous $3.88 Million 1.24%
% of portfolio
0.11%
Previous 0.12%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$111.15 - $128.97 $361,237 - $419,152
3,250 Added 10.38%
34,553 $3.92 Million
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $1.22 Million - $1.31 Million
9,853 Added 45.93%
31,303 $3.88 Million
Q1 2024

May 06, 2024

SELL
$113.24 - $131.95 $64,546 - $75,211
-570 Reduced 2.59%
21,450 $2.83 Million
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $25,846 - $28,127
-258 Reduced 1.16%
22,020 $2.4 Million
Q3 2023

Nov 02, 2023

BUY
$102.95 - $114.33 $465,642 - $517,114
4,523 Added 25.47%
22,278 $2.29 Million
Q2 2023

Aug 11, 2023

BUY
$108.61 - $118.38 $109,478 - $119,327
1,008 Added 6.02%
17,755 $2.05 Million
Q1 2023

May 09, 2023

BUY
$102.94 - $114.86 $49,720 - $55,477
483 Added 2.97%
16,747 $1.78 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $56,486 - $72,423
646 Added 4.14%
16,264 $1.8 Million
Q3 2022

Nov 02, 2022

BUY
$84.53 - $94.96 $44,631 - $50,138
528 Added 3.5%
15,618 $1.35 Million
Q2 2022

Aug 02, 2022

BUY
$83.49 - $94.64 $246,462 - $279,377
2,952 Added 24.32%
15,090 $1.38 Million
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $183,701 - $205,917
-2,499 Reduced 17.07%
12,138 $996,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $102,565 - $128,476
1,419 Added 10.74%
14,637 $1.12 Million
Q3 2021

Nov 02, 2021

SELL
$71.68 - $78.83 $117,483 - $129,202
-1,639 Reduced 11.03%
13,218 $993,000
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $82,895 - $91,690
1,179 Added 8.62%
14,857 $1.16 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $238,186 - $280,559
3,459 Added 33.85%
13,678 $1.05 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $1.41 Million - $1.57 Million
-19,687 Reduced 65.83%
10,219 $836,000
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $360,850 - $409,026
-4,931 Reduced 14.15%
29,906 $2.48 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $68,307 - $77,726
970 Added 2.86%
34,837 $2.69 Million
Q1 2020

May 11, 2020

BUY
$63.36 - $87.82 $264,464 - $366,560
4,174 Added 14.06%
33,867 $2.61 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $282,701 - $318,995
3,644 Added 13.99%
29,693 $2.7 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $122,564 - $133,600
-1,611 Reduced 5.82%
26,049 $2.19 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $59,084 - $69,025
846 Added 3.16%
27,660 $2.32 Million
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $1.18 Million - $1.34 Million
16,941 Added 171.59%
26,814 $2.23 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $3,849 - $4,466
-59 Reduced 0.59%
9,873 $754,000
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $194,992 - $229,299
3,380 Added 51.59%
9,932 $705,000
Q2 2018

Aug 13, 2018

BUY
$50.83 - $59.72 $59,826 - $70,290
1,177 Added 21.9%
6,552 $398,000
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $157,721 - $183,316
3,095 Added 135.75%
5,375 $293,000
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $117,921 - $137,058
-2,314 Reduced 50.37%
2,280 $293,000
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $14,143 - $16,889
274 Added 6.34%
4,594 $258,000
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $5,749 - $6,186
98 Added 2.32%
4,320 $277,000
Q2 2017

Aug 10, 2017

BUY
N/A
4,222
4,222 $271,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Portfolio

Follow Empirical Financial Services, LLC D.B.A. Empirical Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.